November 2021 - ELIAS Animal Health

ELIAS Animal Health Expands Scientific Advisory Board

Nov. 23, 2021 — ELIAS Animal Health, a clinical stage development company advancing novel treatments for cancer in companion animals, announces the appointment Zachary Wright, DVM, DACVIM (Oncology) and Amanda Foskett, DVM, DACVIM (Oncology) to its scientific advisory board. “I am pleased to add two veterinary oncologists to our advisory board," said Tammie Wahaus, CEO of ELIAS Animal Health. "Drs. Wright and Foskett bring an invaluable perspective on the advancement of animal cancer treatments.” Dr. Wright is the Medical Director at Animal Diagnostics Clinic at VCA Hospitals in Dallas, Texas. He received his veterinary medical degree from Texas A&M University and completed a one year rotating small animal internship in medicine and surgery at VCA West Los Angeles Animal Hospital in Los Angeles, California. Dr. Wright completed his residency in small animal oncology at Texas A&M University and became a Diplomate of the American College of Veterinary Internal Medicine-Oncology in [...]

By Jessica Wiley|2024-04-30T11:48:54-06:00November 23rd, 2021|Categories: News|Tags: elias leadership|0 Comments

ELIAS Animal Health In-Licenses Oncolytic Vaccinia Virus Treatment for Pet Animals from Genelux Corporation

Agreement grants ELIAS Animal Health the worldwide right to development and commercialization of V-VET1 for the diagnosis, prevention and treatment of cancer in veterinary medicine Nov. 18, 2021 -- Genelux Corporation, a clinical-stage immunotherapy company, recently announced a licensing agreement with ELIAS Animal Health for V-VET1, its clinical-stage animal health product candidate. V-VET1 is a vaccinia viral strain which selectively replicates in cancer cells causing cell death (apoptosis). ELIAS Animal Health is planning clinical trials to evaluate and develop V-VET1 as a potential new immunotherapy option for veterinary oncologists. “We are thrilled to announce our exclusive license for V-VET1 to help veterinarians treat the many pets who are diagnosed with cancer every year,” said Tammie Wahaus, CEO of ELIAS Animal Health. “Companion animal cancer treatments have made little progress in the past few decades, and this partnership is an exciting step in broadening the cancer treatment options available in veterinary medicine.” [...]

By Jessica Wiley|2024-04-30T11:41:10-06:00November 18th, 2021|Categories: News|Tags: cancer immunotherapy, genelux corporation, oncolytic virus|0 Comments

Change Is Hard But Worth the Effort | Part 4: Create a Culture of Change

Change. We’ve established that it’s hard all around - for people, leaders, and entire organizations. It requires commitment, willingness to do things differently, and being open to other thought processes and approaches. Successfully executing change is a big deal! However, since companies are ever-moving, growing, shifting, and improving, it’s a never-ending endeavor. By creating a culture of change, organizations can circumvent much of the uncertainty and resistance that accompanies isolated changes. Creating an environment that is change-conducive, flexible, and adaptive supports your team as they shift and adjust - a much better alternative than tossing them into the shark tank! Forbes published an article a couple of years ago that spotlights 14 Ways To Build a Company Culture That Embraces Change. We’ve discussed much of what they cover in the first 3 installments of this series: Why Change is Hard, The Change Maze, and How to Manage Change. The authors point out a few more essentials that, when effectively implemented, [...]

By Tammie Wahaus|2022-01-08T14:46:32-06:00November 4th, 2021|Categories: Blog|0 Comments